Amanta Healthcare Quarterly Results for Trading Insights
AMANTA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹11 Cr
QMarch 2025
Amanta Healthcare Quarterly Results Key Highlights
- Revenue of ₹276 Cr in March 2025 (+0.0% vs March 2025, -2.1% vs March 2024)
- Net Profit of ₹11 Cr in March 2025 (+0.0% vs March 2025, +175.0% vs March 2024)
- EBITDA of ₹61 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 22.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹3.71 in March 2025 (+0.0% vs March 2025)
Amanta Healthcare Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 278 | 276 | 282 | 263 | 227 | 0.7% | - |
| Net Profit (₹ Cr) | 13 | 11 | 4 | -2 | 55 | - | - |
| EBITDA (₹ Cr) | 61 | 61 | 59 | 56 | 54 | - | - |
| EPS (₹) | 4.60 | 3.71 | 1.35 | -0.79 | 20.54 | - | - |
| Operating Margin (%) | 22.0% | 22.0% | 21.0% | 20.0% | 23.0% | - | - |
Amanta Healthcare Share Price Trend Around Quarterly Results
Visualize Amanta Healthcare's 1-year price movement across quarterly results — ideal for logging trades in Amanta Healthcare share price
chart using Tickjournal. All values in ₹.
Related Pages for Amanta Healthcare
Additional stock information and data for AMANTA
Revenue Trend (₹ Cr)
March 2023
263
March 2024
282
March 2025
276
2026
278
Net Profit Trend (₹ Cr)
March 2023
-2
March 2024
4
March 2025
11
2026
13
Operating Margin Trend (%)
March 2023
20.0%
March 2024
21.0%
March 2025
22.0%
2026
22.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Amanta Healthcare quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores